Eris Therapeutics Private Limited

Produces and markets pharmaceuticals and conducts research in healthcare and pharmaceuticals.

2009 | Rajkot, Gujarat (India) | Merged
Last Updated: January 16, 2025

Eris Therapeutics Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 15 Year, 6 Months
  • Last Filing with ROC 31 Mar 2020
  • Revenue Growth %
  • Profit Growth 57.58%
  • Ebitda 17.65%
  • Net Worth -1.62%
  • Total Assets -1.48%

About Eris Therapeutics

Eris Therapeutics Private Limited (ETPL) is Amalgamated company established on 30 Jul 2009 with its office registered at Rajkot, Gujarat, India and has been running since 15 Year, 6 Months with a paid up capital of 0.10 M. According to MCA records, 3 Directors are linked to this company as of 16 Jan 2025.

Company Details

  • Location

    Rajkot, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230GJ2009PTC057670

  • Company No.

    057670

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    30 Jul 2009

  • Date of AGM

    28 Sep 2020

  • Date of Balance Sheet

    31 Mar 2020

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

Who are the key members and board of directors at Eris Therapeutics?

Board Members (3)

Name Designation Appointment Date Status
Kaushal Shah Country flag representing In Director 25-Nov-2009 Current
Amit Bakshi Country flag representing In Director 30-Jul-2009 Current
Inderjeet Negi Country flag representing In Director 25-Nov-2009 Current

Financial Performance of Eris Therapeutics.

Eris Therapeutics Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 57.58% increase in profit. The company's net worth dipped by a decrease of 1.62%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-1.48%
Profit or Loss
57.58%
Net Worth
-1.62%
EBITDA
17.65%

What is the Ownership and Shareholding Structure of Eris Therapeutics?

In 2019, Eris Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Eris Therapeutics?

Eris Therapeutics has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eris Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris Therapeutics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Eris Therapeutics

Recent activity within the organization

  • Annual General Meeting

    Eris Therapeutics Private Limited last Annual general meeting of members was held on 28 Sep 2020 as per latest MCA records.

    28 Sep 2020

  • Balance Sheet

    Eris Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Ahmedabad.

    31 Mar 2020

  • Director Appointment

    Kaushal Kamlesh Shah was appointed as a Director was appointed as a Director on 25 Nov 2009 & has been associated with this company since 15 years 2 months .

    25 Nov 2009

  • Director Appointment

    Inderjeet Singh Negi was appointed as a Director was appointed as a Director on 25 Nov 2009 & has been associated with this company since 15 years 2 months .

    25 Nov 2009

  • Director Appointment

    Amit Indubhushan Bakshi was appointed as a Director was appointed as a Director on 30 Jul 2009 & has been associated with this company since 15 years 6 months .

    30 Jul 2009

  • Company Incorporation

    Eris Therapeutics Private Limited was registered on 30 Jul 2009 with Roc Ahmedabad & aged 15 years 6 months as per MCA records.

    30 Jul 2009

Frequently asked questions

  • Eris Therapeutics Private Limited was incorporated on 30 Jul 2009.

  • The authorized share capital of Eris Therapeutics Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Eris Therapeutics Private Limited.

    • Kaushal Kamlesh Shah
    • Amit Indubhushan Bakshi
    • Inderjeet Singh Negi
  • As per Ministry of Corporate Affairs (Mca), the registered address of Eris Therapeutics Private Limited is Vision 2020 Sf-209 150Ft Ring Road Nr. Lijjat Papad Plt-3-4, India, Rajkot, Gujarat, 360007.

  • The corporate identification number (CIN) of Eris Therapeutics Private Limited is U24230GJ2009PTC057670 and the company number is 057670 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Eris Therapeutics Private Limited is https://www.erislifesciences.com

  • The financial reports for the fiscal year 2019 indicates that The net worth of Eris Therapeutics Private Limited has experienced an downturn of -1.62%.

  • The most recent Balance Sheet for Eris Therapeutics Private Limited was filed with the ROC on 31 Mar 2020.

Similar Companies Based on Drug Formulation & Development